heparin sodium · 3m · NDA 017027

Lipo-Hepin

Earliest generic entry, as listed · earliest of 11 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 11

NDA · productFormStrengthListed expiry
017027 · 001 · discontinuedinjectable, injection1,000 UNITS/0.5MLopen
017027 · 002 · discontinuedinjectable, injection5,000 UNITS/0.5MLopen
017027 · 003 · discontinuedinjectable, injection10,000 UNITS/0.5MLopen
017027 · 004 · discontinuedinjectable, injection20,000 UNITS/0.5MLopen
017027 · 005 · discontinuedinjectable, injection40,000 UNITS/MLopen
017027 · 006 · discontinuedinjectable, injection1,000 UNITS/MLopen
017027 · 007 · discontinuedinjectable, injection20,000 UNITS/MLopen
017027 · 008 · discontinuedinjectable, injection5,000 UNITS/MLopen
017027 · 009 · discontinuedinjectable, injection10,000 UNITS/MLopen
017027 · 010 · discontinuedinjectable, injection7,500 UNITS/0.5MLopen
017027 · 011 · discontinuedinjectable, injection15,000 UNITS/0.5MLopen